The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Gh Research Ireland competitive analysis

Loading summary...

Latest patents of Gh Research Ireland opposed by its competitors

Explore Gh Research Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3927338
Oct 9, 2024Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Use In Treating Mental Disorders1
EP3927337
Mar 20, 20245-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Depression2
EP4313945
Mar 13, 2024Crastalline Hydrobromide Salt Of 5-Meo-Dmt1

Latest PTAB cases involving Gh Research Ireland

Discover the latest PTAB cases involving Gh Research Ireland, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Gh Research Ireland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GH RESEARCH IRELAND - 4 - -
PORTA SOPHIA1 - 1 -
SCORPIO21 - - -
STRAWMAN339 - - -